[在胃癌治疗中使用化合物ligustrazine的网络药理学研究]
Wei Xu1, Zhaomin Deng1, Xin Wang1
1( 610041) Department of Gastroenterology and Hepatology, Laboratory for Aging and Cancer Research, Frontiers Science Center for Disease-related Molecular Network, National Clinical Research Center for Geriatrics ,State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China.
甲基氨酸通过向ELANE和MPO基因,显示出胃癌治疗的潜力. 这种化合物可以通过各种信号通路和免疫细胞透来影响癌症的发展.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 胃癌仍然是一个重大的全球健康挑战.
- 识别新型治疗剂和了解它们的机制对于改善患者的治疗结果至关重要.
研究的目的:
- 研究四甲基在胃癌中的治疗潜力和潜在机制.
- 为了确定关键的分子标和受四甲基酸影响的途径.
主要方法:
- 网络药理学分析被用来选四甲基酸的潜在标.
- 进行了基因功能注释和癌症基因组图谱 (TCGA) 的临床数据分析.
- 对关键基因进行了免疫透,miRNA,GSEA,GSVA和GWAS分析.
主要成果:
- 在胃癌中确定了14个甲基pyrazine的潜在治疗点.
- 发现关键基因ELANE和MPO显著影响胃癌存活率和免疫细胞透.
- ELANE和MPO涉及到与胃癌发展相关的多种信号通路.
结论:
- 甲基pyrazine可能通过调节已识别的目标,ELANE和MPO,对胃癌产生治疗作用.
- 这项研究强调了四甲基拉作为胃癌治疗剂的潜力,需要进一步研究.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
